Table 1.
Comparison of patient characteristics between diabetes and non-diabetes patients.
| Diabetesn = 289 | Non-diabetesn = 2576 | P-value | |
|---|---|---|---|
| Age (y) median ± IQR | 57.4 ± 10.0 | 54.1 ± 8.7 | <0.0001 |
| Male sex (%) | 159 (55.0%) | 1151 (44.7%) | 0.0001 |
| Race (%) | <0.0001 | ||
| White/European Ancestry (EA) | 223 (77.2%) | 2271 (88.2%) | |
| Black/African Ancestry (AA) | 29 (10.0%) | 140 (5.4%) | |
| Asian | 16 (5.5%) | 72 (2.8%) | |
| Other | 21 (7.3%) | 93 (3.6%) | |
| Hispanic ethnicity (%) | 24 (8.3%) | 197 (7.6%) | 0.74 |
| Family history of CRC | 11 (3.8%) | 142 (5.5%) | 0.27 |
| Median BMI (kg/m2) ± IQR | 31.2 ± 9.1 | 27.3 ± 6.6 | <0.0001 |
| Smoking (%) | 0.0015 | ||
| Current (within a year) | 43 (14.9%) | 333 (12.9%) | |
| Quit (at least a year) | 105 (36.3%) | 710 (27.6%) | |
| Never | 141 (48.8%) | 1533 (59.5%) | |
| Aspirin use (%)3 | 87 (30.1%) | 273 (10.6%) | <0.0001 |
| Fellow involvement (%) | 50 (17.3%) | 476 (18.5%) | 0.63 |
| Quality of colonoscopic prep | 0.0002 | ||
| Excellent | 47 (16.3%) | 604 (23.4%) | |
| Good | 198 (68.5%) | 1730 (67.2%) | |
| Fair | 26 (9.0%) | 108 (4.2%) | |
| Undocumented | 18 (6.2%) | 134 (5.2%) | |
| Insurance (%) | <0.0001 | ||
| Commercial | 167 (57.8%) | 1857 (72.1%) | |
| Medicare | 42 (14.5%) | 244 (9.5%) | |
| Medicaid | 71 (24.6%) | 423 (16.4%) | |
| Self-pay | 9 (3.1%) | 52 (2.0%) | |
| Diabetes Type | |||
| Type I | 7 (2.4%) | ||
| Type 2 | 282 (97.6%) | ||
| Median FPG (mg/dl) ± IQR1 | 129 ± 51 | ||
| Median HbA1c % ± IQR2 |
7.2 ± 1.5 (55 mmol/mol) |
||
| Anti-diabetes medications (%) | |||
| None | 30 (10.4%) | ||
| Insulin | 59 (20.4%) | ||
| Metformin | 190 (65.7%) | ||
| Sulfonylurea | 73 (25.3%) | ||
| DPP4 inhibitors | 38 (13.1%) | ||
| Thiazolidinedione | 10 (3.5%) | ||
| GLP1 agonists | 5 (1.7%) | ||
| SGLT-2 inhibitor | 3 (1.0%) | ||
| Meglitinides | 1 (0.3%) | ||
| Acarbose | 0 (0%) | ||
1FPS missing values = 16 (5.5%). 2HbA1c missing values = 143 (49.5%). 3Asprin use missing values = 9.
Significant P-values are bolded.